ETAO International Co., Ltd. (NASDAQ: ETAO) Stock Competitors & Peer Comparison
See ETAO's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ETAO and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ETAO | $1.91 | -31.79% | 9.8M | -0.01 | -$175.64 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $59.13 | -2.91% | 11.6B | 47.69 | $1.24 | N/A |
| BTSGU | $195.51 | -3.30% | 11.5B | 176.79 | $1.11 | N/A |
| TEM | $64.04 | -9.41% | 11.2B | -128.08 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $96.37 | +3.19% | 8.1B | 22.52 | $4.28 | N/A |
| TXG | $61.54 | -5.10% | 7.8B | -104.31 | -$0.59 | N/A |
| HNGE | $87.35 | -5.92% | 6.8B | 46.70 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
ETAO vs GEHCV Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas GEHCV's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, ETAO is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
ETAO vs BTSG Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BTSG has a market cap of 11.6B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while BTSG trades at $59.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BTSG's P/E ratio is 47.69. In terms of profitability, ETAO's ROE is -13.69%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, ETAO is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
ETAO vs BTSGU Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BTSGU has a market cap of 11.5B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while BTSGU trades at $195.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BTSGU's P/E ratio is 176.79. In terms of profitability, ETAO's ROE is -13.69%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, ETAO is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
ETAO vs TEM Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, TEM has a market cap of 11.2B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while TEM trades at $64.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas TEM's P/E ratio is -128.08. In terms of profitability, ETAO's ROE is -13.69%, compared to TEM's ROE of -0.55%. Regarding short-term risk, ETAO is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
ETAO vs SGFY Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SGFY's P/E ratio is 70.91. In terms of profitability, ETAO's ROE is -13.69%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, ETAO is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
ETAO vs HQY Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HQY has a market cap of 8.1B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while HQY trades at $96.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HQY's P/E ratio is 22.52. In terms of profitability, ETAO's ROE is -13.69%, compared to HQY's ROE of +0.11%. Regarding short-term risk, ETAO is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
ETAO vs TXG Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, TXG has a market cap of 7.8B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while TXG trades at $61.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas TXG's P/E ratio is -104.31. In terms of profitability, ETAO's ROE is -13.69%, compared to TXG's ROE of -0.09%. Regarding short-term risk, ETAO is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
ETAO vs HNGE Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while HNGE trades at $87.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HNGE's P/E ratio is 46.70. In terms of profitability, ETAO's ROE is -13.69%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, ETAO is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
ETAO vs RCM Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas RCM's P/E ratio is -102.21. In terms of profitability, ETAO's ROE is -13.69%, compared to RCM's ROE of +0.00%. Regarding short-term risk, ETAO is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check RCM's competition here
Waystar Holding Corp. (NASDAQ: WAY)
ETAO vs WAY Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, WAY has a market cap of 5B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while WAY trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas WAY's P/E ratio is 17.38. In terms of profitability, ETAO's ROE is -13.69%, compared to WAY's ROE of +0.04%. Regarding short-term risk, ETAO is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check WAY's competition here
Doximity, Inc. (NYSE: DOCS)
ETAO vs DOCS Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while DOCS trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas DOCS's P/E ratio is 17.47. In terms of profitability, ETAO's ROE is -13.69%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, ETAO is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check DOCS's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
ETAO vs HTFL Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HTFL has a market cap of 4.1B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while HTFL trades at $47.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HTFL's P/E ratio is -23.77. In terms of profitability, ETAO's ROE is -13.69%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, ETAO is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
ETAO vs ONEM Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ONEM's P/E ratio is -7.77. In terms of profitability, ETAO's ROE is -13.69%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, ETAO is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
ETAO vs PRVA Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, PRVA has a market cap of 2.6B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while PRVA trades at $20.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas PRVA's P/E ratio is 99.00. In terms of profitability, ETAO's ROE is -13.69%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, ETAO is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
ETAO vs NXGN Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas NXGN's P/E ratio is -266.00. In terms of profitability, ETAO's ROE is -13.69%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, ETAO is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
ETAO vs OMCL Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while OMCL trades at $33.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas OMCL's P/E ratio is 17.32. In terms of profitability, ETAO's ROE is -13.69%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, ETAO is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check OMCL's competition here
Omada Health (NASDAQ: OMDA)
ETAO vs OMDA Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while OMDA trades at $23.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas OMDA's P/E ratio is 338.43. In terms of profitability, ETAO's ROE is -13.69%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, ETAO is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
ETAO vs AGTI Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas AGTI's P/E ratio is -71.79. In terms of profitability, ETAO's ROE is -13.69%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, ETAO is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
ETAO vs CERT Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CERT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CERT's P/E ratio is 20.87. In terms of profitability, ETAO's ROE is -13.69%, compared to CERT's ROE of -0.07%. Regarding short-term risk, ETAO is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
ETAO vs GDRX Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while GDRX trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas GDRX's P/E ratio is 11.03. In terms of profitability, ETAO's ROE is -13.69%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, ETAO is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
ETAO vs TDOC Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while TDOC trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas TDOC's P/E ratio is -6.57. In terms of profitability, ETAO's ROE is -13.69%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, ETAO is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check TDOC's competition here
HealthStream, Inc. (NASDAQ: HSTM)
ETAO vs HSTM Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HSTM has a market cap of 858.3M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while HSTM trades at $29.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HSTM's P/E ratio is 40.81. In terms of profitability, ETAO's ROE is -13.69%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, ETAO is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
ETAO vs CCLDO Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CCLDO's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, ETAO is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CCLDO's competition here
Phreesia, Inc. (NYSE: PHR)
ETAO vs PHR Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, PHR has a market cap of 750.4M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while PHR trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas PHR's P/E ratio is 43.36. In terms of profitability, ETAO's ROE is -13.69%, compared to PHR's ROE of +0.03%. Regarding short-term risk, ETAO is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
ETAO vs SOPH Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SOPH has a market cap of 682.9M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SOPH trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SOPH's P/E ratio is -7.33. In terms of profitability, ETAO's ROE is -13.69%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, ETAO is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SOPH's competition here
Claritev Corporation (NYSE: CTEV)
ETAO vs CTEV Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CTEV has a market cap of 669.3M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CTEV trades at $39.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CTEV's P/E ratio is -2.31. In terms of profitability, ETAO's ROE is -13.69%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, ETAO is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
ETAO vs MPLN-WT Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, ETAO is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for ETAO.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
ETAO vs ACCD Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ACCD's P/E ratio is -3.08. In terms of profitability, ETAO's ROE is -13.69%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, ETAO is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
ETAO vs SHCR Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SHCR's P/E ratio is -3.76. In terms of profitability, ETAO's ROE is -13.69%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, ETAO is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
ETAO vs EVH Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, EVH has a market cap of 518M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while EVH trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas EVH's P/E ratio is 35.42. In terms of profitability, ETAO's ROE is -13.69%, compared to EVH's ROE of -0.99%. Regarding short-term risk, ETAO is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check EVH's competition here
NRC Health (NASDAQ: NRC)
ETAO vs NRC Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, NRC has a market cap of 492.4M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while NRC trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas NRC's P/E ratio is 26.65. In terms of profitability, ETAO's ROE is -13.69%, compared to NRC's ROE of +0.48%. Regarding short-term risk, ETAO is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
ETAO vs SLGC Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SLGC's P/E ratio is -3.04. In terms of profitability, ETAO's ROE is -13.69%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, ETAO is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
ETAO vs SLGCW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, ETAO's ROE is -13.69%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, ETAO is more volatile compared to SLGCW. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
ETAO vs TBRG Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas TBRG's P/E ratio is 9.37. In terms of profitability, ETAO's ROE is -13.69%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, ETAO is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
ETAO vs MPLN Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MPLN's P/E ratio is -0.23. In terms of profitability, ETAO's ROE is -13.69%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, ETAO is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
ETAO vs SY Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SY has a market cap of 314.9M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SY trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SY's P/E ratio is -7.27. In terms of profitability, ETAO's ROE is -13.69%, compared to SY's ROE of -0.16%. Regarding short-term risk, ETAO is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
ETAO vs TRHC Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas TRHC's P/E ratio is -4.27. In terms of profitability, ETAO's ROE is -13.69%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, ETAO is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
ETAO vs SMFR Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SMFR's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, ETAO is more volatile compared to SMFR. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
ETAO vs SPOK Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SPOK has a market cap of 222.4M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SPOK trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SPOK's P/E ratio is 17.75. In terms of profitability, ETAO's ROE is -13.69%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, ETAO is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
ETAO vs AMWL Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, AMWL has a market cap of 202.2M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while AMWL trades at $11.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas AMWL's P/E ratio is -2.69. In terms of profitability, ETAO's ROE is -13.69%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, ETAO is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check AMWL's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
ETAO vs LFMDP Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, LFMDP has a market cap of 156.9M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while LFMDP trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas LFMDP's P/E ratio is -709.24. In terms of profitability, ETAO's ROE is -13.69%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, ETAO is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check LFMDP's competition here
LifeMD, Inc. (NASDAQ: LFMD)
ETAO vs LFMD Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, LFMD has a market cap of 151.9M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while LFMD trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas LFMD's P/E ratio is -6.28. In terms of profitability, ETAO's ROE is -13.69%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, ETAO is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check LFMD's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
ETAO vs OPRX Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, OPRX has a market cap of 149.2M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while OPRX trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas OPRX's P/E ratio is 7.29. In terms of profitability, ETAO's ROE is -13.69%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, ETAO is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check OPRX's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
ETAO vs CPSI Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CPSI's P/E ratio is -183.80. In terms of profitability, ETAO's ROE is -13.69%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, ETAO is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
ETAO vs HCAT Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HCAT has a market cap of 117.5M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while HCAT trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HCAT's P/E ratio is 7.95. In terms of profitability, ETAO's ROE is -13.69%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, ETAO is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
ETAO vs AUGX Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas AUGX's P/E ratio is -4.99. In terms of profitability, ETAO's ROE is -13.69%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, ETAO is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
ETAO vs CCLD Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CCLD has a market cap of 105.8M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CCLD trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CCLD's P/E ratio is 9.58. In terms of profitability, ETAO's ROE is -13.69%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, ETAO is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
ETAO vs WORX Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas WORX's P/E ratio is -6.40. In terms of profitability, ETAO's ROE is -13.69%, compared to WORX's ROE of -0.35%. Regarding short-term risk, ETAO is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for ETAO.Check WORX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
ETAO vs DH Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, DH has a market cap of 84.7M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while DH trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas DH's P/E ratio is 3.09. In terms of profitability, ETAO's ROE is -13.69%, compared to DH's ROE of -0.79%. Regarding short-term risk, ETAO is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
ETAO vs FORA Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas FORA's P/E ratio is -24.11. In terms of profitability, ETAO's ROE is -13.69%, compared to FORA's ROE of -0.17%. Regarding short-term risk, ETAO is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
ETAO vs CCLDP Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CCLDP's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, ETAO is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
ETAO vs SNCE Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SNCE's P/E ratio is -0.27. In terms of profitability, ETAO's ROE is -13.69%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, ETAO is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
ETAO vs AKLI Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas AKLI's P/E ratio is -0.71. In terms of profitability, ETAO's ROE is -13.69%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, ETAO is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
ETAO vs SHLT Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SHLT's P/E ratio is -3.87. In terms of profitability, ETAO's ROE is -13.69%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, ETAO is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMD)
ETAO vs ONMD Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ONMD has a market cap of 33M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while ONMD trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ONMD's P/E ratio is -3.62. In terms of profitability, ETAO's ROE is -13.69%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, ETAO is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check ONMD's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
ETAO vs SHCRW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, ETAO's ROE is -13.69%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, ETAO is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
ETAO vs ONMDW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ONMDW has a market cap of 31.1M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ONMDW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, ETAO is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
ETAO vs STRM Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas STRM's P/E ratio is -2.40. In terms of profitability, ETAO's ROE is -13.69%, compared to STRM's ROE of -0.65%. Regarding short-term risk, ETAO is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
ETAO vs RNLX Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas RNLX's P/E ratio is -0.33. In terms of profitability, ETAO's ROE is -13.69%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, ETAO is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
ETAO vs LIFW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas LIFW's P/E ratio is -0.02. In terms of profitability, ETAO's ROE is -13.69%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, ETAO is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
ETAO vs BBLN Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BBLN's P/E ratio is -0.04. In terms of profitability, ETAO's ROE is -13.69%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, ETAO is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check BBLN's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
ETAO vs BFRG Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BFRG has a market cap of 10.1M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while BFRG trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BFRG's P/E ratio is -1.18. In terms of profitability, ETAO's ROE is -13.69%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, ETAO is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check BFRG's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
ETAO vs MGRX Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MGRX has a market cap of 6.8M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while MGRX trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MGRX's P/E ratio is -0.30. In terms of profitability, ETAO's ROE is -13.69%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, ETAO is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
ETAO vs UPH-WT Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, ETAO is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for ETAO.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
ETAO vs UPH Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas UPH's P/E ratio is -0.07. In terms of profitability, ETAO's ROE is -13.69%, compared to UPH's ROE of -1.05%. Regarding short-term risk, ETAO is more volatile compared to UPH. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check UPH's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
ETAO vs PEARW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas PEARW's P/E ratio is -0.00. In terms of profitability, ETAO's ROE is -13.69%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, ETAO is more volatile compared to PEARW. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
ETAO vs PEAR Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas PEAR's P/E ratio is -0.08. In terms of profitability, ETAO's ROE is -13.69%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, ETAO is more volatile compared to PEAR. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
ETAO vs OTRK Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas OTRK's P/E ratio is -0.02. In terms of profitability, ETAO's ROE is -13.69%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, ETAO is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
ETAO vs CMAX Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CMAX's P/E ratio is -0.00. In terms of profitability, ETAO's ROE is -13.69%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, ETAO is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
ETAO vs BFRGW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, ETAO's ROE is -13.69%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, ETAO is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check BFRGW's competition here
Aclarion, Inc. (NASDAQ: ACON)
ETAO vs ACON Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ACON's P/E ratio is -0.27. In terms of profitability, ETAO's ROE is -13.69%, compared to ACON's ROE of -0.59%. Regarding short-term risk, ETAO is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
ETAO vs LIFWZ Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, ETAO is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check LIFWZ's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
ETAO vs HCTI Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HCTI has a market cap of 975.4K. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while HCTI trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HCTI's P/E ratio is -0.11. In terms of profitability, ETAO's ROE is -13.69%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, ETAO is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
ETAO vs VSEEW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, ETAO's ROE is -13.69%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, ETAO is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for ETAO.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
ETAO vs MSPRZ Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, ETAO is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for ETAO.Check MSPRZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
ETAO vs VSEE Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, VSEE has a market cap of 245.6K. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while VSEE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas VSEE's P/E ratio is -0.03. In terms of profitability, ETAO's ROE is -13.69%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, ETAO is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check VSEE's competition here
Akerna Corp. (NASDAQ: KERN)
ETAO vs KERN Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas KERN's P/E ratio is -0.01. In terms of profitability, ETAO's ROE is -13.69%, compared to KERN's ROE of -0.20%. Regarding short-term risk, ETAO is more volatile compared to KERN. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
ETAO vs KERNW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas KERNW's P/E ratio is -0.00. In terms of profitability, ETAO's ROE is -13.69%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, ETAO is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for ETAO.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
ETAO vs LIFWW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas LIFWW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, ETAO is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
ETAO vs CMAXW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CMAXW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, ETAO is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
ETAO vs ZCMD Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ZCMD has a market cap of 32.1K. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while ZCMD trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, ETAO's ROE is -13.69%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, ETAO is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
ETAO vs ACONW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ACONW has a market cap of 13.6K. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ACONW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, ETAO is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
ETAO vs MTBCP Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MTBCP's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, ETAO is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
ETAO vs MTBCO Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MTBCO's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, ETAO is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check MTBCO's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
ETAO vs CNVY Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CNVY's P/E ratio is -71.50. In terms of profitability, ETAO's ROE is -13.69%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, ETAO is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CNVY's competition here
NantHealth, Inc. (NASDAQ: NH)
ETAO vs NH Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, NH has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas NH's P/E ratio is -0.12. In terms of profitability, ETAO's ROE is -13.69%, compared to NH's ROE of +0.35%. Regarding short-term risk, ETAO is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for ETAO.Check NH's competition here
Cerner Corporation (NASDAQ: CERN)
ETAO vs CERN Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CERN has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CERN's P/E ratio is 55.84. In terms of profitability, ETAO's ROE is -13.69%, compared to CERN's ROE of +0.14%. Regarding short-term risk, ETAO is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CERN's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
ETAO vs KURIU Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas KURIU's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, ETAO is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check KURIU's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
ETAO vs AFFX Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas AFFX's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, ETAO is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check AFFX's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
ETAO vs CHNG Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CHNG's P/E ratio is -152.72. In terms of profitability, ETAO's ROE is -13.69%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, ETAO is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CHNG's competition here
Castlight Health, Inc. (NYSE: CSLT)
ETAO vs CSLT Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CSLT's P/E ratio is -37.27. In terms of profitability, ETAO's ROE is -13.69%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, ETAO is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CSLT's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
ETAO vs CHNGU Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CHNGU's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, ETAO is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check CHNGU's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
ETAO vs NAVA Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas NAVA's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, ETAO is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for ETAO.Check NAVA's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
ETAO vs IMS Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, IMS has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas IMS's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to IMS's ROE of +0.27%. Regarding short-term risk, ETAO is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check IMS's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
ETAO vs SMFRW Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SMFRW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, ETAO is more volatile compared to SMFRW. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check SMFRW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
ETAO vs MSPRV Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MSPRV's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MSPRV's ROE of N/A. Regarding short-term risk, ETAO is more volatile compared to MSPRV. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBC)
ETAO vs MTBC Comparison September 2026
ETAO International Co., Ltd. (NASDAQ: ETAO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MTBC's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, ETAO is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for ETAO.Check MTBC's competition here